Similarly, metabolomic disorders such as Type 2 diabetes are associated with higher alanine concentrations compared to non‐diabetics individuals [38], which may be beneficial due to its potential to enhance both oxidative and non‐oxidative glucose metabolism, as well as stimulate insulin secretion [41]. This evidence concerns the gene INS and type 2 diabetes mellitus.